Medicinal and botanical sales in the US have shown fluctuating trends over the past decade. In 2023, sales stood at $11.8 billion. From 2013 to 2014, there was a significant decline of approximately 10%, followed by minor variations and an overall downward trend until 2020. The sales slightly picked up in 2021 with a 5.39% increase and have since maintained a stable yet modest upward trend with minor year-on-year increases. The Compound Annual Growth Rate (CAGR) over the last five years shows a minimal positive trend of 0.12%.
Future trends indicate a steady but slow growth rate with projected sales reaching $11.872 billion by 2028, translating to a forecasted 5-year CAGR of 0.1% and a 5-year growth rate of 0.49%.
Future trends to watch for:
- Emerging markets and new product innovations in the medicinal and botanical sector.
- Impact of regulatory changes and approval processes on sales growth.
- Increased consumer interest in natural and alternative medicine options.
